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Abstract
 This document presents the recommendations of the Polish Medical Society of Radiology (PLTR) and 
the Polish Society of Polish Society of Rheumatology (PTR) regarding the standards of collaboration 
between radiologists and rheumatologists so as to optimize the diagnostics and treatment of pa-
tients with rheumatic diseases of the musculoskeletal system, including rheumatoid arthritis and 
spondyloarthropathies.
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Background
This document presents the recommendations of the 
Polish Medical Society of Radiology (PLTR) and the Polish 
Society of Rheumatology (PTR) regarding the standards 
of collaboration between radiologists and rheumatologi-
sts in order to standardize the diagnostic procedure and 
treatment of patients with rheumatic diseases of the 
musculoskeletal system, including rheumatoid arthritis 
and spondyloarthropathies.
The document has been prepared on the basis of local 
clinical expertise as well as the guidelines of the European 
Society of Skeletal Radiology (ESSR), the Assessment of 
SpondyloArthritis International Society (ASAS) and Euro-
pean League Against Rheumatism (EULAR) [1–9].
Following issues are discussed in the recommendations:
•	 the role of MRI in the current criteria for classification 
of rheumatic diseases;
•	 MRI referrals;
•	 the range of MRI scans;
•	 MRI protocols;
•	 MRI interpretation;
•	 the role of MRI in treatment.
The role of MRI in the criteria for 
classification of rheumatic diseases
In clinical practice, MRI of musculoskeletal system is 
performed in patients with rheumatic diseases to dia-
gnose inflammation within peripheral joints, tendon 
sheaths, bursae, the spine, entheses of the ligaments, 
joint capsule and fascia as well as complications of the-
se conditions.
Most commonly, MRI is performed in differential dia-
gnosis of:
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1.  Spondyloarthropathies (SpA; spondyloarthritis; in-
flammation of the spine accompanied by inflamma-
tion of peripheral joints), including:
a.  Axial spondyloarthropathy: inflammation of the 
sacroiliac joints (sacroiliitis) and the spine (spon-
dylitis);
b.  Peripheral spondyloarthropathy: inflammation of 
the peripheral joints (arthritis), tendon sheaths 
(tenosynovitis; tendovaginitis) and entheses (en-
thesitis).
2.  Rheumatoid arthritis (RA): inflammations within pe-
ripheral joints, tendon sheaths, bursae (bursitis) and 
the spine;
3.  Juvenile idiopathic arthritis (JIA): inflammation wi-
thin peripheral joints (including temporo-manidibular 
where MRI is the method of choice), tendon sheats;
4.  Any rheumatic diseases involving musculoskeletal 
system without diagnosis established on the basis of 
radiographic or ultrasonographic findings: peripheral 
joints, tendon sheaths, bursae, the spine and muscles.
Main indications for MRI in patients with rheumatic 
diseases include:
•	 Assessment of inflammatory lesions, particularly 
early stages involving joint cavities (synovial thicke-
ning, synovial enhancement following contrast agent 
administration, effusion, bone marrow edema, ero-
sions, inflammatory cysts);
•	 Assessment of inflammatory lesions in tendon she-
aths, tendons and their entheses;
•	 Assessment of muscles’ inflammation (myositis); 
•	 Assessment of complications of rheumatic disorders, 
e.g cervical spine lesions in the course of RA.
The advantages of MRI are:
•	 Ability to assess all articular surfaces;
•	 Ability to assess inflamed bone marrow (bone mar-
row edema cannot be detected by any other modali-
ty; it may precede articular cartilage destruction);
•	 Ability to assess the spine and the spinal cord (e.g. 
spinal stenosis, spondylodiscitis, atlantooccipital al-
terations along with the assessment of the activity of 
inflammation);
•	 Higher specificity due to contrast-enhanced scans;
•	 Semiquantitative and quantitative inflammation as-
sessment by means of the intensity and extent of 
contrast enhancement analysis.
MRI in the classification criteria
Axial spondyloarthropathy
MRI of sacroiliac joints is most frequently performed 
in patients with chronic back pain (Table I) whose ra-
diographs do not fulfill the modified New York criteria 
(Table II).
MRI is most commonly performed to [7]:
•	 Visualize inflammatory lesions in sacroiliac joints, 
particularly in young patients or patients with short 
history of the disease, if clinical and radiological fin-
dings are insufficient to confirm the clinical suspicion 
of the disease;
•	 Monitor the activity of the disease, with frequency of 
repeated MRI depending on clinical presentation;
•	 Monitor structural (chronic) changes of sacroiliac jo-
ints and the spine, considering radiography as a mo-
dality of choice.
Peripheral spondyloathropathy
Patients presenting clinical symptoms of peripheral 
arthritis, enthesitis, or edema of the finger(s) are refer-
red for MRI, as X-ray and ultrasound findings are not dia-
gnostic or normal (Table III), in order to determine the 
spectrum and activity of inflammatory lesions [7].
Table I. ASAS 2010 criteria for classification of axial 
spondyloarthritis [2, 3, 9]
Back pain ≥ 3 months and age at onset < 45 years
Sacroiliitis on imaging*
+
≥ 1 SpA feature**
or
HLA-B27 – positive
+
≥ 2 other SpA features**
* Active (acute) inflammation on MRI or definite radiographic 
sacroiliitis according to the modified New York criteria (1984) are 
highly suggestive of sacroiliitis associated with SpA
** SpA features: inflammatory back pain (at least 4 of the follo-
wing symptoms must occur: 1. pain onset before the age of 40;  
2. insidious onset; 3. improvement with exercise; 4. no improve-
ment with rest; 5. pain at night, with improvement upon getting 
up), peripheral arthritis, enthesitis, uveitis, dactylitis, psoriasis, 
Crohn’s disease (CD) or ulcerative colitis (UC), good response to 
non-steroidal antiinflammatory drugs, family history of SpA, HLA-
-B27, elevated CRP
Table II. Modified New York criteria for ankylosing 
spondylitis (1984) [9]
Clinical criteria
•		Low	back	pain	for	more	than	3	months	that	improves	with	
exercise, but is not released by rest
•		Limitation	of	motion	of	the	lumbar	spine	in	the	sagittal	
and frontal planes
•		Reduced	chest	expansion	(relative	to	normal	values	corre-
lated for age and sex)
Radiological criterion
•		Definite	radiological	lesions,	i.e.	sacroiliitis	grade	2–4	
biliterally or grade ≥ 3 unilaterally
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Rheumatoid arthritis
Imaging studies are not included in current ACR/ 
EULAR criteria for diagnosing RA (2010). MRI is recom-
mended in case of diagnostic uncertainties when X-ray 
and ultrasound findings are inconclusive [8]. MRI allows 
detection of inflammatory changes in joint cavities, ten-
don sheaths and bursae. MRI is the only imaging modali-
ty to evaluate bone marrow edema, which together with 
the synovium lining joint cavities, sheaths and bursae as 
well as the intra- and extraarticular adipose tissue, may 
be an area of active inflammation in the course of RA.
In addition, ACR/EULAR criteria recommend MRI to [8]:
•	 determine the prognosis (bone marrow edema and 
synovitis are risk factors for the progression of struc-
tural changes);
•	 predict the treatment responses;
•	 monitor the disease activity and progression;
•	 assess the activity of inflammatory lesions and atlan-
tooccipital alterations;
•	 assess inflammatory lesions not detected in the clini-
cal examination.
Juvenile idiopathic arthritis
MRI is useful for detection and evaluation of the ac-
tivity of inflammation in joint cavities, tendon sheaths 
and bursae, as well as for the monitoring of treatment 
and complications recognition [10].
MRI referrals
Based on the clinical examination, the clinician de-
termines the anatomical region to be included in the 
MRI examination.
The referral should include the following:
•	 The purpose and the rationale for the examination;
•	 Suspected diagnosis;
•	 Information required for the proper conduct of a ra-
diological medical procedure (including symptoms 
and physical examination findings);
•	 Results of previous examinations, mainly imaging 
scans;
•	 Information on current treatment, its efficacy, and 
biological treatment if planned;
•	 Medical history (diseases, injuries, surgeries, particu-
larly of the examined area);
•	 An information if the comparison with the previous 
scan is required.
Previous MRI results, X-ray and ultrasound scans of 
the examined anatomical region should be delivered.
In case of patients with implanted foreign bodies 
including prosthetic implants, the referring physician 
should ask the patient contraindications for magne-
tic resonance examination. Foreign bodies consisting 
ferromagnetic materials are a contraindication for MRI 
generating strong magnetic field. If indicated, the exa-
mination may be performed using a low field scanner.
Intravenous contrast agent is frequently admini-
stered. Due to the risk of nephrogenic systemic fibro-
sis (NSF) following the administration of gadolinium in 
patients with renal failure (the risk varies for different 
contrast agents and the stage of renal failure), patients 
should provide the plasma creatinine level or glomerular 
filtration rate (GFR).
The contrast agent is administered on the approval 
of the radiologist, based on the referral data and the 
overview of the unenhanced scan.
The range of MRI scans
According to the referral, examination of specific 
anatomical regions is performed, using special spinal or 
body phased-array coils.
If indicated, whole body MRI scans are also acquired 
in search for active inflammation.
When referring patients to peripheral joint imaging 
using a low field scanner dedicated for examination of 
small joints, one should consider its limited field of view 
of around 12 cm.
Table III. ASAS classification criteria for peripheral spondyloarthritis [3, 5]
Peripheral arthritis
(usually asymmetric inflammation of joints within lower extremities, enthesitis, dactylitis – “sausage fingers”)
plus ≥ 1 of SpA symptoms or ≥ 2 other SpA symptoms
≥ 1 SpA feature:
•		Psoriasis
•		CD	or	UC
•		Preceding	infection
•		HLA-B27
•		Uveitis
•		Sacroiliitis	on	X-ray	or	MRI
≥ 2 other SpA features:
•		Arthritis
•		Enthesitis
•		Dactylitis/sausage-like	toe	or	digit
•		Inflammatory	back	pain
•		Family	history	of	SpA
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For axial SpA, the Polish Medical Society of Radio-
logy recommends whole-spine MRI. When examining 
hands, a scan of the opposite side should also frequently 
be acquired.
MRI protocols
MRI protocols can be adjusted according to local 
experience, taking into consideration the scanner spe-
cifications, available coils and image quality in parti-
cular sequences. TIRM/STIR, T2 FS, and PD FS sequen-
ces may be used interchangea.
The size of the field of view and the matrix as well as 
the slice thickness should be appropriately adjusted so 
as to ensure maximum image quality within reasonable 
examination times. The recommended slice thickness is 
3 mm, with interslice gap of 0.3 mm.
Contrast agent is administered intravenously if indi-
cated.
Listed below are MRI scanning protocols recommen-
ded by the Polish Medical Society of Radiology for the 
assessment of rheumatic changes within the musculo-
skeletal system. Sequences considered by the Authors 
to be obligatory for visualization of inflammatory and 
destructive lesions within the joints are in bold.
Sacroiliac joints
•	sagittal T2-weighteda
•	axialb PD FS
•	coronal obliquec TIRM/STIR
•	coronal oblique T1-weighted
•	coronal oblique T1 FS contrast-enhanced
a Including the sacroiliac joints for accurate planning of the coronal 
oblique plane and the assessment of the L/S spine
b Axial – a transverse slice of sacroiliac joints perpendicular to the 
coronal oblique slice
c Coronal oblique – slice of sacroiliac joints in coronal plane relative 
to the tangent of the posterior surface of S2 vertebral body
The spine
•	sagittal T1-weighted
•	sagittal T2 TIRM/STIR
•	sagittal T2-weighted
•	axial T2-weighted
Optional
•	coronal T2-weighted
•	sagittal T1 contrast-enhanced
 
The handa
•	axial T2 FS or PD FS or T2 TIRM/STIR (to be selected 
depending on the MRI scanner)
•	coronal T1-weighted
•	coronal T2 TIRM/STIR or PD FS (to be selected depen-
ding on the MRI scanner)
•	coronal T1 FS
Optional
•	coronal T1 FS contrast-enhanced
•	axial T1 FS contrast-enhanced
•	sagittal PD FS
•	dynamic scan: coronal T1-weighted
aAnatomically, the hand includes the wrist, the metacarpus and 
the digits
The ankle joint and the foota
•	coronal PD FS or T2 TIRM/STIR
•	axial T1-weighted
•	axial PD FS or T2 TIRM/STIR
•	sagittal PD FS
•	coronal PD
•	axial T1 FS
Optional
•	axial T1 FS contrast-enhanced
•	axial T1 FS contrast-enhanced
•	sagittal T1 FS with contrast-enhanced
•	dynamic scan: transverse T1-weighted
aCoronal slice along the longitudinal body axis axial slice: perpen-
dicular to the longitudinal body axis
The acromioclavicular joint
•	axial T1-weighted
•	axial PD FS or TIRM/STIR
•	coronal T1-weighted
•	coronal PD FS or TIRM/STIR
•	sagittal PD FS or TIRM/STIR
•	Obligatory: minimum two PD FS or two TIRM/STIR se-
quences and minimum one T1-weighted sequence from 
listed above
Optional
•	coronal T1 FS contrast-enhanced
•	axial T1 FS contrast-enhanced
•	dynamic scan: coronal T1-weighted
The elbow joint
•	axial T1-weighted
•	axial PD FS or TIRM/STIR
•	coronal PD or TIRM/STIR
•	coronal PD FS or TIRM/STIR
•	sagittal T1-weighted
•	sagittal PD FS
•	Obligatory: minimum two PD FS or two TIRM/STIR se-
quences and minimum one T1-weighted sequence from 
listed above
Optional
•	axial T1 FS contrast-enhanced
•	coronal T1 FS contrast-enhanced
•	sagittal T1 FS contrast-enhanced
•	dynamic scan: sagittal T1-weighted
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The hip joint
•	coronal T1-weighted
•	axial PD FS or STIR/TIRM
•	coronal PD FS or TIRM/STIR
•	axial T1-weighted
Optional
•	axial T1 FS contrast-enhanced
•	coronal T1 FS contrast-enhanced
•	dynamic scan: coronal T1-weighted
The knee joint
•	axial T1-weighted
•	axial PD FS
•	sagittal PD FS or STIR/TIRM
•	coronal T1-weighted
•	coronal PD FS or STIR/TIRM
Optional
•	axial T1 FS contrast-enhanced
•	sagittal T1 FS contrast-enhanced
•	coronal T1 FS contrast-enhanced
•	dynamic scan: transverse T1-weighted
Temporomandibular joints
Assessment of inflammatory lesions:
•	axial or coronal T1-weighted
•	axial T2 STIR/TIRM
•	coronal T2 STIR/TIRM
•	coronal T2-weighted
Assessment of articular discs and joint mobility:
•	sagittal oblique PD (articular disc assessment)
•	sagittal oblique PD FS (mouth open and closed)
MRI interpretation
Subject to the assessment are the T1, T2, PD-weigh-
ted and fat saturation or STIR/TIRM sequences.
The assessments are performed in at least two per-
pendicular planes.
In rheumatology, MRI scans with intravenous ad-
ministration of contrast agent are performed mainly in 
order to:
•	 determine the activity of inflammaion within the sy-
novium;
•	 determine the activity of erosions;
•	 confirm the presence of inflammatory lesions if ima-
ges acquired using other sequences are non-diagno-
stic;
•	 make the differential diagnosis (posttraumatic, in-
flammatory, neoplastic lesions).
Bone marrow edema in rheumatological patients is 
indicative of osteitis. It is manifested as early as seve-
ral weeks after the onset of the disease and is conside-
red a very early imaging marker of inflammation. Bone 
marrow edema is correlated with clinical activity of the 
disease and elevated levels of acute phase inflamma-
tion markers, i.e. erythrocyte sedimentation rate and 
C-reactive protein. At the early phase of the disease, 
bone marrow edema is reversible and may resolve under 
treatment. Bone marrow edema is a radiological symp-
tom preceding the development of erosions.
MRI of sacroiliac joints
In the diagnosis of early sacroiliitis, MRI scans are 
evaluated for active and chronic inflammatory changes 
(Table IV). The MRI-based diagnosis of early sacroiliitis 
requires detection of bone marrow edema. According 
to ASAS criteria, the remaining active inflammatory 
changes, such as synovitis, capsulitis and enthesitis are 
suggestive of sacroiliitis on the condition of concomi-
tant bone marrow edema in the adjacent areas [9].
MRI scan report should contain a description of acti-
ve and chronic inflammatory changes, indicate (if possi-
ble) the number and location of these changes for dia-
gnostic reasons, and for monitoring of treatment.
Active inflammatory lesions in MRI scans:
•	 Bone marrow edema (BME) – bone marrow edema 
is visible as an area of hyperintense signal on T2-we-
ighted images, STIR/TIRM sequence and following 
contrast administration, and as a low signal area in 
T1-weighted images. In sacroiliitis, BME is located 
subchondrally in the iliac or sacral bone; it may ac-
company bone erosions.
•	 Synovitis – synovitis is seen as a thickening of syno-
vium and hyperintense signal on T2-weighted, STIR/
TIRM and contrastenhanced T1-weighted FS sequen-
ces; it is often concomitant to effusion.
•	 Capsulitis – capsulitis is seen as a thickening of 
the sacroiliac joint capsule and hyperintense signal 
on T2-weighted, STIR/TIRM and contrast-enhanced 
Table IV. Types of typical MRI lesions of the sacroiliac joints according to ASAS [9]
Active inflammatory lesions Chronic inflammatory lesions
•	Bone marrow edema
•	Capsulitis
•	Synovitis
•	Enthesitis
•	Subchondral sclerosis
•	Erosions
•	Fat deposition
•	Bony bridges, ankylosis
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T1-weighted FS sequences; it is often concomitant to 
effusion.
•	 Enthesitis – enthesitis is seen as hyperintense signal 
of sacroiliac ligaments or capsule entheses on STIR/
TIRM or T1 FS contrast-enhanced images. Features of 
bone marrow edema are usually detected in the bony 
part of the enthesis.
Chronic inflammatory changes in MRI scans
1.  Subchondral sclerosis of the sacroiliac joint: low-in-
tensity signal in all sequences.
2.  Erosions: bony defects at the joint margin, including 
active erosions (i.e. filled with inflammatory tissue of 
low signal intensity on T1-weighted images without 
contrast enhancement and high signal intensity on 
contrast enhanced T1-weighted, PD FS, and STIR/
TIRM images) and inactive erosions (no abnormal en-
hancement following contrast agent administration).
3.  Subchondral fatty conversion of bone marrow: hyper-
intense signal on T1, T2, and PD-weighted images sup-
pressed in fat-saturation sequences, no abnormal en-
hancement following contrast agent administration.
4.  Ankylosis, or bony union across the joint.
MRI of the spine
In rheumatoid patients, MRI of the spine is usually 
performed in order to assess the atlantooccipital region 
(synovial pathologies, odontoid erosions and inflamma-
tory cysts, C1/C2 subluxation, C2 disc herniation) and to 
search for inflammatory lesions in the course of axial 
spondyloarthropathies.
Typical for axial SpA findings include inflamed ver-
tebral bodies, including bone marrow edema in the an-
terior parts of the endplates (shiny corners or corner 
inflammatory lesions, CIL) as a potential site for the de-
velopment of erosions or syndesmophytes in the course 
of ankylosing spondylitis, as well as intervertebral discs, 
intervertebral joints and costovertebral joints inflamma-
tion.
In addition, areas of fatty marrow conversion, syn-
desmophytes, erosions, and ankylosis are also visible in 
the scans. Interpretation of the images is similar to that 
of sacroiliitis.
MRI of peripheral joints
Inflammatory lesions in joint cavities, tendon she-
aths and bursae: thickening of the synovium, enhance-
ment of inflamed synovium, effusion, erosions, inflam-
matory cysts (geodes), ligaments and tendons damage.
Synovitis is assessed on T1-weighted fat-satura-
tion sequences following contrast administration. The 
enhancement within the synovial membrane should 
be examined within no longer than 5–10 minutes from 
contrast administration. After this time, the contrast 
agent permeates into the synovial fluid. Fibrosis wi-
thin the synovium is the subject to low contrast en-
hancement.
Bone marrow edema in the course of the inflamma-
tion is seen as hyperintense areas on T2, PD-weighted 
images, best visible in fat-saturated or STIR/TIRM sequ-
ences, hypointense on T1-weighted images, with enhan-
cement following contrast agent administration.
Inflammatory cysts are inflammatory focal lesions 
within the bone marrow. They are more limited than the 
areas of bone marrow edema.
Erosions are trabecular bone defects with not prese-
rved cortical bone continuity.
Other changes detectable in MRI  
of the musculoskeletal system  
in rheumatological patients
•	 Tendinitis secondary to tenosynovitis, tendon dama-
ge;
•	 Inflammatory lesions of subdermal tissue in the co-
urse of scleroderma [11];
•	 Dermatomyositis, polymyositis (muscles inflamma-
tion, biopsy site identification);
•	 Deficiency-related fractures (sacral bone, femoral 
neck, metaphyses, trabecular bone);
•	 Avascular necrosis;
•	 Neuropathies;
•	 Rheumatoid nodules;
•	 Polymyalgia rheumatica (identification of inflamma-
tion).
MRI assessment is usually qualitative. Examples of 
semiquantitative assessment of inflammatory lesions in 
the carpal and metacarpophalangeal joints in RA inclu-
de: RAMRIS (Rheumatoid Arthritis MRI Scoring System) 
[12], PsAMRIS (Psoriatic Arthritis MRI Scoring System) 
[13], or the Canadian scoring system for sacroiliac joint 
inflammation [14].
The RAMRIS system includes definitions of basic RA 
symptoms at individual disease stages, descriptions of 
MRI scanning sequences and semi-quantitative asses-
sment of the inflammatory-destructive lesions range wi-
thin the carpal and metacarpophalangeal joints [15, 16]. 
The use of RAMRIS is an attempt to standardize the as-
sessment of the severity and the monitoring of the tre-
atment of inflammatory lesions in carpal joints.
According to RAMRIS assessment:
•	 The intensity of synovitis is assessed in three areas 
of the wrist: distal radioulnar joint; radiocarpal joint; 
metacarpal and carpometacarpal joints.
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 Synovitis is assessed in a staging scale from 0 to 
3 that describes the volume of enhanced synovium 
following contrast agent administration:
–  Stage 0 – no features of synovitis;
–  Stage 1 – mild synovitis (up to 1/3 of joint volume);
–  Stage 2 – moderate synovitis (1/3 to 2/3 of joint 
volume);
–  Stage 3 – severe synovitis (more than 2/3 of joint 
volume);
•	 Bone marrow edema (BME) is assessed separately 
for each carpal bone, distal radial epiphysis, the ulna, 
base parts of metacarpal bones II–V, and metacarpo-
phalangeal joints bones. The stages of bone marrow 
edema (from 0 to 3) reflect the percentage volume of 
bone affected by BME.
–  Grade 0 – no bone marrow edema;
–  Grade 1 – BME affecting up to 1/3 of the assessed 
bone volume;
–  Grade 2 – BME affecting 1/3 to 2/3 of the assessed 
bone volume;
–  Grade 3 – BME affecting more than 2/3 of the as-
sessed bone volume.
•	 Bone destruction grade (erosion size) is assessed 
separately for each of the aforementioned bones in 
a scale of 0–10 reflecting the percentage volume of 
bone being destroyed due to erosion.
Grade 0 – normal bone (no erosions). The successi-
ve grades 1–10 reflect the degree of bone destruction in 
10% increments (e.g. grade 1 – up to 10% of bone volu-
me being destroyed due to erosion; grade 2 from 11% 
to 20% of bone volume being destroyed and so on) [16].
In addition, a very promising method of dynamic con-
trastenhanced MRI (DCE-MRI) for the assessment of the 
degree of enhancement of inflamed synovium has been 
developed in recent years. The examination consists of 
imaging of the same slices at intervals of several seconds, 
before and immediately after intravenous contrast admi-
nistration, over a period of ca. 10 minutes. It allows evalu-
ation of the enhancement degree in the area of inflamed 
synovium. Measurements obtained from the analysis 
reflect synovial perfusion and permeability of capillary 
vessels within the inflamed tissue. They are correlated 
with the degree of synovial vascularization which may be 
particularly useful in monitoring of treatment [17, 18].
The role of MRI in treatment of rheumatic 
diseases
Detection of inflammatory lesions in the sacroiliac 
joints on MRI scans is often crucial for making a diagno-
sis of axial spondyloarthropathy, particularly in the pre-
radiographic stage (before definite lesions are detected 
on radiographs). Early diagnosis and treatment can con-
tribute to a better chance of remission, particularly as 
certain biological agents are documented to be of most 
efficacy in the preradiographic stage of axial spondylo-
arthropathy [19].
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